Enrik Blais obtained a diploma in architectural technology from CÉGEP Lévis-Lauzon in 2004 and joined NFOE the following year. His determination and desire to expand his expertise led him to complete a bachelor's degree in construction engineering at École de Technologie Supérieure (ÉTS) in 2011. Mr. Blais became a partner of the firm in 2018. Over his 22 years of experience, he has acted as project director and project manager on various mandates, overseeing all stages from initial design through to full completion for pharmaceutical production facilities, research laboratories, aerospace installations and advanced industrial facilities for major clients listed below. His experience across a wide variety of construction contract types and his expertise in the design of such buildings have enabled him to successfully deliver fast-track construction projects in close collaboration with multidisciplinary teams, leveraging building information modelling (BIM) throughout.
Experience
- Various projects, GlaxoSmithKline
- Production sector redevelopment, IBM
- Radiopharmaceutical production facility, TerraPower Isotopes
- Facility extension, Jubilant HollisterStier
- Plant expansion, MDA
- Various projects, Pharmascience
- Technical programs, General Dynamics
- Various projects, Pratt & Whitney Canada
- Copper foil manufacturing plant expansion, Solutions Énergétiques Volta Canada
- Multi-building expansion and renovation, Chantier Davie Canada Inc.
- Clinical trial material production infrastructure, Confidential client
- Centre for Photonics Manufacturing (CFPC), NRC
- ARNm vaccine production facility, Moderna
- Manufacturing facility, BD Geneohm
- Pharmaceutical production plant, Capcium
- Vaccine production biotechnology complex, Medicago
- Otto Maass and Pulp & Paper Pavilions, McGill University
- Centennial Center building, McGill University
- Multifunction Complex, Shooting Range, Rigaud Learning Centre, CBSA
- Campus redevelopment, Quartier Évolution
- New film studio, MELS
- Various projects, Merck Canada
- Various projects, Pfizer
